During the past decade, Concorde Medical Group conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 16 clinical trials were completed, i.e. on average, 69.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 12 clinical trials were completed. i.e. 1200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Concorde Medical Group" #1 sponsor was "Celgene" with 9 trials, followed by "Gilead Sciences" with 9 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "American Gastroenterological Association" with 1 trials sponsored and "Bausch Health Americas, Inc." with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Concorde Medical Group" #1 collaborator was "Loyola University Chicago" with 1 trials as a collaborator, "OpenBiome" with 1 trials as a collaborator, "Pharmaceutical Research Associates" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "RX.Health Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Concorde Medical Group" are "Crohn Disease" (7 trials), "Hepatitis C, Chronic" (7 trials), "Ulcerative Colitis" (4 trials), "Cirrhosis" (2 trials) and "Hepatic Encephalopathy" (2 trials). Many other conditions were trialed in "Concorde Medical Group" in a lesser frequency.

Most popular intervention types in "Concorde Medical Group" are "Drug" (33 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Etrolizumab" (3 trials), "GED-0301" (3 trials), "Ozanimod" (3 trials) and "Copegus®" (2 trials). Other intervention names were less common.

The vast majority of trials in "Concorde Medical Group" are 37 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Concorde Medical Group". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Concorde Medical Group, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Concorde Medical Group, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".